The distribution and organization of von Willebrand factor (vWF) multimers on platelets after surface activation have not been fully characterized. In the present study, washed human platelets were allowed to interact with Formvar-coated, electron microscope grids for 20 minutes at 37°C and then fixed. After fixation, cells were washed and then incubated with buffer alone, human plasma, human plasma preincubated with ristocetin (1.2 mg/niL), purified human vWF plus ristocetin, or bovine plasma. 
G
lycoprotein Ib-IX (GPIb-IX) is the principal binding site for von Willebrand factor (vWF) on activated platelets. 13 About 25 000 copies of GPIb-IX cover the surface of the resting platelet, 3 -4 and current evidence indicates that the receptors are randomly dispersed. 5 After activation in suspension, the GPIb-IX complexes undergo downregulation and/or clearance from the exterior surface of the platelet. 6 Michelson and Barnard 7 have shown that thrombin stimulation causes downregulation of GPIb that may be caused by transfer of the receptor to an intraplatelet pool. ADP, plasmin, and exposure to a wound surface in vivo have been found to result in a similar downregulation of platelet surface GPIb-IX complexes. 8 Morphological evidence supporting the clearance of GPIb-IX complexes from the platelet surface to the interior via channels of the surface-connected open canalicular system (OCS) after exposure to thrombin has been presented by Hourdille et al. 9 Subsequent work by the same group has demonstrated that vWF
The primary function of GPIb-IX is to serve as the receptor that attaches platelets to the exposed subendothelium in vivo. 13 Binding of vWF to the receptor is essential for the hemostatic function of platelets, particularly under high shear conditions. 11 - 13 If the clearance of GPIb-IX or GPIb-IX/vWF complexes after platelet stimulation is important to their physiological activity, it would seem worthwhile to examine the distribution of GPIb-IX receptors and vWF on platelets after their interaction with surfaces rather than in suspension. We have recently demonstrated that GPIb-IX 14 and GPIIb-IIIa 15 are not spontaneously redistributed on fully spread, surface-activated platelets, even after further stimulation by thrombin. 14 The present study has examined the distribution of vWF bound to receptors on surface-activated platelets. The results indicate that vWF is dispersed edge to edge on fully spread platelets in a serpentine, linear organization.
Methods
Blood for the present study was obtained after informed consent from donors who regularly participated in our studies and who were known to be free of all medications. Blood obtained by venipuncture was mixed immediately with citrate-citric acid-dextrose (CCD), pH 6.5, in a ratio of 9 parts blood to 1 part anticoagulant. 16 Platelet-rich plasma was obtained by centrifugation of the whole blood for 20 minutes at 100g. Platelets from platelet-rich plasma were washed twice with an equal volume of CCD (93 mmol/L sodium citrate, 70 mmol/L citric acid, and 140 mmol/L dextrose, pH 6.5) containing 5 mmol/L adenosine and 3 mmol/L theophylline. 17 The final pellet was resuspended in Hank's balanced salt solution without calcium and adjusted to 50 000 platelets per microliter. Human platelet-poor plasma was prepared from platelet-rich plasma by centrifugation at lOOOg for 10 minutes. Bovine platelet-poor plasma was prepared in the same manner. 18 Most experiments were carried out with fresh bovine and human plasmas, but snap-frozen and stored plasmas were also used successfully.
Small drops, 50 juL in volume, of the washed platelet suspension were placed on carbon-stabilized, Formvar grids and allowed to interact with this surface for 20 minutes at 37°C. 1920 After this period, nonattached platelets were washed away with Hank's buffered salt solution (HBSS), and the platelets were fixed with 1% paraformaldehyde in phosphate-buffered saline (PBS). After fixation for 15 to 30 minutes, the spread platelets were rinsed several times in HBSS and exposed to one of several different incubations. Control spread platelets were incubated with PBS alone or staph-protein A-gold (PAG) (Amersham, Arlington Heights, 111) alone. Other grids were exposed to human plasma, human plasma previously incubated with 1.2 mg/mL ristocetin antibiotic, or bovine plasma. In some experiments the fixed, spread platelets were treated with monoclonal antibodies specific for the GPIb-IX complex (API, 10 mg/mL) or for GPIIb-IIIa (AP2, 10 mg/mL), kindly provided by Dr Tom Kunicki, Scripps Institute, La Jolla, Calif; these platelet preparations were thoroughly rinsed before exposure to PBS, human plasma, human plasma incubated with ristocetin, or bovine plasma. Detection of vWF was accomplished by exposing the grids of spread platelets coated with vWF multimers to a polyclonal antibody, Dako AO82 (Dako, Santa Barbara, Calif) against vWF. Grids were rinsed several times in PBS and incubated with 5-or 10 -nm conjugates of PAG. After further rinsing in PBS, the grids were air dried and examined in a Philips 301 electron microscope. Each experiment was repeated at least three times. 
Control Studies
Purified human vWF in glycerol was kindly provided by Dr David Fass of the Mayo Clinic. Dr Walter Bowie of the same institution supplied serum from pigs homozygous for vWF deficiency. Dr J. Roger Edson of the University of Minnesota offered serum from a patient with severe type 3a von Willebrand disease. The purified vWF protein was dialyzed against HBSS for 2 hours before use to remove the glycerol. vWF protein and human serum were exposed to 1.2 mg/mL ristocetin just before use. Each reagent was employed in separate experiments with fully spread, normal human platelets as described above. Platelets were allowed to spread for 20 minutes and then fixed in 1% paraformaldehyde in PBS. After rinsing several times in HBSS, the fixed, spread cells were incubated with vWF protein, vWFdeficient human serum, or vWF-deficient porcine serum. vWF, if present, was detected by treating it with the commercial antibody to vWF, followed by rinsing and exposure of the treated cells to PAG.
Results

Spread Platelets
Fully spread platelets appeared almost transparent to the electron beam (Fig 1) . Incubation on drops of PBS did not influence this appearance. Occasional electrondense bodies, the storage sites for adenine nucleotides, serotonin, and calcium destined for secretion, remained in the spread platelet cytoplasm. Because of the contrast provided by a slightly greater density of the spread platelets, the cells could easily be distinguished from Formvar without enhancement. Only platelets that had filled in spaces between all or nearly all pseudopodial extensions were considered to be fully spread. PBS had no effect on the appearance of fully spread platelets, and PAG alone did not adhere to the surface-activated cells to any significant degree (Fig 1) .
Endogenous vWF
Immunogold staining of spread platelet surfaces with the polyclonal antibody to vWF, followed by PAG, revealed concentrations of electron-dense probes in the central area of the spread cells (Fig 2) . Residual discoid platelets on the grids were not stained by anti-vWF antibody-PAG complexes (not shown).
Spread Platelets Plus Human Plasma
Exposure of spread platelets to human plasma followed by immunocytochemical staining for vWF failed to demonstrate the deposition of plasma protein on the platelets. Rather, the polyclonal antibody to vWF stained the central areas as it did on spread platelets fixed and reacted for vWF in the absence of human plasma shown in Fig 2. 
Spread Platelets and Bovine Plasma
The appearance of dendritic and fully spread platelets that were incubated with bovine plasma and stained for vWF was striking. Serpentine linear densities covered the surfaces of fully spread and spreading platelets from edge to edge (Figs 3 and 4) . To be sure that vWF from bovine plasma was binding to GPIb and not GPIIb-IIIa, experiments with monoclonal antibodies were carried out. Incubation of spread platelets with API or anti-glycocalicin antibody, before treatment with bovine plasma, prevented deposition of linear densities and staining by anti-vWF antibody followed by PAG. Exposure of the spread platelets to AP2 before exposure to bovine plasma had no effect on the deposition or staining of vWF.
Spread Platelets and Rlstocetin-Activated Human Plasma
In contrast to platelets that were exposed to human plasma alone, fully spread cells incubated with human platelet-poor plasma treated with ristocetin and stained with a polyclonal antibody to vWF, followed by staph-PAG, revealed gold conjugates over the entire exposed surface from edge to edge (Fig 5) . The appearance was identical to that of spread platelets after exposure to bovine plasma followed by exposure to antibody to vWF and PAG. Particles of gold were not organized in a purely random fashion. Instead, they were deposited on serpentine, linear densities that give a mottled appearance to the platelet surface. Immunogold conjugates were virtually confined to the serpentine densities ( Fig  6) . Only a few particles of gold were found in clear areas adjacent to them.
The possibility that vWF was binding to GPIIb-IIIa was explored as above by incubating the spread platelets at 4°C with monoclonal antibodies for 30 minutes before fixation and exposure to ristocetin-activated human plasma. Prior exposure of the spread platelets to API (Fig 7) or anti-glycocalicin antibodies prevented deposition of exogenous vWF. The antibody to vWF and PAG deposited on such platelets was probably released from the spread platelets, since the irregular serpentine densities were absent. Treatment of spread platelets with AP2, a monoclonal antibody against GPIIb-IIIa, did not affect the deposition of linear densities of vWF from ristocetin-activated human plasma or their staining by anti-vWF antibody and PAG (Fig 8) .
Control Studies
Human platelets spread on grid surfaces for 20 minutes were fixed and incubated with ristocetin-activated, purified human vWF (kindly provided by Dr David Fass, Mayo Clinic) and stained first with the antibody to vWF and then with PAG. Serpentine linear densities stained specifically by gold particles were present on the spread platelet surfaces. The appearance observed with purified human vWF was identical to that found when fixed, spread platelets were incubated with either bovine plasma or ristocetin-activated human plasma. Plasma from a patient with severe type 3a von Willebrand disease was kindly provided by Dr J. Roger Edson. Incubation of vWF-deficient plasma with fixed, fully spread platelets, followed by staining with anti-vWF antibody and PAG, failed to reveal serpentine densities or deposition of PAG on the cells. Serum from pigs severely deficient in vWF kindly provided by Dr Walter Bowie of the Mayo Clinic was also tested. Incubation of the vWF-deficient porcine serum with fixed, spread platelets did not result in deposition of linear densities or significant staining by anti-vWF antibody and PAG.
Discussion
The present study used ultrastructural immunocytochemistry to identify the organization of vWF on fully spread, surface-activated platelets. Addition of ristocetin-activated human plasma, bovine plasma, or purified human vWF to spread platelets resulted in the deposition of linear, serpentine densities that formed an irregular mosaic from edge to edge on the spread cells. Addition of a polyclonal antibody to vWF, followed by staph-PAG, confirmed that the linear densities were multimers of vWF.
The organization of vWF multimers in irregular, linear arrangements slightly more dense than the adjacent, spread platelet membrane may explain the appearance of vWF on thin sections of thrombin-stimulated platelets in suspension. 10 In those studies, vWF multimers resembled aggregations or clumps separated from each other on thin-sectioned platelets. Preliminary observations on thin sections of the fully spread platelets covered with serpentine, linear multimers of vWF yielded exactly the appearance identified in thin sections by Hourdille et al.
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The edge-to-edge distribution of vWF multimers on fully spread platelets is in close agreement with our observations regarding localization of GPIb-IX and GPIIb-IIIa on fully spread platelets.
14 Previous reports, together with evidence obtained in the present investigation, indicate that shape change, pseudopod formation, and conversion to spread forms does not cause spontaneous clearance of binding sites for vWF from the exposed platelet surface. All of these phenomena are manifestations of actin filament assembly and isometric contraction in spread platelets. As shown earlier, 14 even thrombin treatment of fully spread cells does not cause spontaneous translocation and removal of GPIb-IX to platelet centers or the OCS.
The findings of the present study do not question the work that has demonstrated that GPIb-IX, like GPIIbIlla, is a mobile receptor. 610 Published observations of many investigators, 2127 including studies from our laboratory, 19202829 have clearly demonstrated the mobility of the major receptor complexes on activated platelets. However, the present study and earlier work indicate that platelets can undergo either activation by thrombin in suspension or complete spreading as a result of surface activation, without revealing any sign of spontaneous clearance of the receptor complexes. 15 Thus, downregulation, 78 when interpreted as the removal of GPIb-IX receptors to the platelet interior or as the clearance of GPIb-IX from the surface to the channels of the OCS on thrombin-activated platelets in suspension, 9 does not accurately reflect the early responses of platelets to surface stimulation.
vWF serves as a bridge between GPIb-IX and constituents of the exposed subendothelium, particularly collagen.
13
- 30 Platelets cannot move constituents of the subendothelium. Instead, GPIb-IX forms stable complexes with the surface and permits the platelet membrane to move. As actin filaments assemble, they drive out the platelet membrane to fill the spaces between extended pseudopods, resulting in full spreading. During this process, channels of the OCS are evaginated, thus contributing to the marked increase in surface area of the spread cells. If platelets did not have mobile integrin and nonintegrin receptors that permitted the membrane to move through them after they formed stable receptor-ligand complexes, spreading would be impossible.
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Mobile GPIIb-IIIa receptors serve in the same manner. Fibrinogen that is coupled to gold particles readily adheres to GPIIb-IIIa expressed on suspension-or surface-activated platelets and is cleared to channels of the OCS.
192024 - 27 However, the function of bound fibrinogen is to serve as a bridge between GPIIb-IIIa and subendothelial constituents or other platelets. The stable receptor-ligand complexes formed between surfaces are incapable of movement. However, they do permit platelets to spread on the exposed surface and on each other to seal off sites of vascular injury.
In conclusion, results of the present study have shown that intraplatelet vWF, most likely associated with a-granules, is transferred to the central zone of fully spread, surface-activated platelets. 34 Addition of ristocetin-activated human plasma or bovine plasma to the spread cells results in deposition of multimers of vWF over the entire platelet surface. The multimers are organized in irregular, serpentine densities that are specifically stained by anti-vWF antibody. The edge-toedge distribution of the multimers of vWF on spread platelet surfaces indicates that a significant spontaneous clearance of GPIb-IX complexes on surface-activated cells does not take place during the spreading process. Moreover, the function of GPIb-IX complexes as receptors for vWF remains unchanged on platelets spread on surfaces.
